AHA investigators surveyed participating clinics to capture a baseline of practice patterns for CKM syndrome assessment. The analysis included responses from 97 clinical sites that completed a standardized questionnaire between August 2025 and June 2026. Most sites reported carrying out basic screening for the components that define CKM syndrome — but far fewer reported using newer, guideline-recommended tools introduced to support coordinated assessment and risk stratification.
The survey was part of the American Heart Association’s Cardiovascular-Kidney-Metabolic Health Initiative, a learning collaborative and quality improvement effort. Participating sites were selected for the initiative based on factors such as community burden of CKM syndrome, structural and societal influences, rural location and organization type. The study team presented these results as a baseline snapshot prior to broader implementation activities.
Sites reported high rates of standard screening: 75% screened for CKM-related conditions and 73% said they systematically tested populations for CKM risk factors. Social drivers of health screening also reached 75% according to respondents. Short, practical metrics—blood pressure, glucose, lipids—appear to be embedded in routine practice at most sites.
Despite this, uptake of newer assessment frameworks was limited. Only 28% of surveyed sites reported using the PREVENT equations for cardiovascular risk estimation. Even fewer — 22% — indicated use of CKM syndrome staging in clinical practice. Measurement of waist circumference, a simple metabolic risk metric, was reported as standard practice by only 22% of sites. These gaps reveal a divergence between screening for individual risks and adopting coordinated, multi-domain assessment tools designed to integrate heart, kidney and metabolic risk.
The authors noted that CKM staging provides a four-step framework that reflects disease evolution: excess or dysfunctional fat deposition; chronic kidney disease and/or metabolic risk factors; subclinical heart disease or high-risk equivalents; and clinical heart disease. The staging model is intended to clarify where a patient sits along a continuum and to identify opportunities for early intervention.
Investigators described the PREVENT equations as contemporary risk tools derived from large U.S. datasets and designed to estimate 10- and 30-year cardiovascular risk in adults aged 30–79 without known heart disease. The survey team observed that both CKM staging and PREVENT equations can more precisely identify patient risk and potential care management opportunities compared with single-domain screening alone.
The standardized questionnaire sought to document implementation of onboarding assessments and the status of new screening and risk estimation tools across sites in the initiative. Respondents indicated that 92% of the reporting clinics identified as outpatient facilities, with a primary care focus. Organization types were distributed as 44% safety net, 39% non-academic and 16% academic.
Data collection captured which CKM-related screenings were conducted: social drivers of health, screening for clinical comorbidities and active population-level screening for CKM risk factors were the most commonly reported practices. The survey did not report additional operational details such as exact screening instruments used, frequency of screening, or how PREVENT or CKM staging were integrated into clinical workflows; the source did not provide those methodological specifics.
Study limitations are clearly documented by the authors. Although the initiative includes about 150 sites, only 97 sites had submitted data at the time of analysis. The survey relied on self-reported data from clinical sites and is therefore subject to recall bias and potential misclassification. Selection bias is also possible because clinics were chosen for participation in the initiative based on predefined criteria.
Investigators described this work as a baseline assessment that will inform targeted implementation efforts. Ongoing assessments, the study team said, will expand the dataset and provide a more complete picture of barriers, facilitators and progress in adopting CKM-coordinated care practices. The findings reported here are from an abstract to be presented at AHA Scientific Sessions 2026; the authors and the release emphasize that these results are preliminary until published in a peer-reviewed manuscript.
The article ends with the authors’ stated aim that broader adoption of CKM staging and the PREVENT equations could help identify higher-risk patients and support more integrated, whole-person care, while acknowledging the need for continued data collection and implementation evaluation.